Skip to main content
SpringerLink
Log in

Target blood pressure in diabetes patients with hypertension —What is the accumulated evidence in 2011?

  • Review
  • Published:
Journal of Zhejiang University SCIENCE B Aims and scope Submit manuscript

Abstract

There is overwhelming evidence that hypertension is an important risk factor for both macrovascular and microvascular complications in patients with diabetes, but the problem remains to identify appropriate goals for preventive therapies. A number of guidelines (the European Society of Cardiology (ESC)/European Association for the Study of Diabetes (EASD) 2007, the Joint National Committee (JNC)-VII 2003, the American Diabetes Association (ADA) 2011) have for example advocated a blood pressure goal of less than 130/80 mmHg, but this suggestion has been challenged by findings in recent trials and meta-analyses (2011). The European Society of Hypertension (ESH) therefore recommends a systolic blood pressure goal of “well below” 140 mmHg. Based on evidence from both randomized controlled trials (hypertension optimal treatment (HOT), action in diabetes and vascular disease: preterax and diamicron MR controlled evaluation (ADVANCE), action to control cardiovascular risk in diabetes (ACCORD)) and observational studies (ongoing telmisartan alone and in combination with ramipril global endpoint trial (ONTARGET), international verapamil-trandolapril study (INVEST), treat to new targets (TNT), and the National Diabetes Register (NDR)), it has been shown that the benefit for stroke reduction remains even at lower achieved blood pressure levels, but the risk of coronary events may be uninfluenced or even increased at lower systolic blood pressure levels. In a recent meta-analysis, it was therefore concluded that the new recommended goal should be 130–135 mmHg systolic blood pressure for most patients with type 2 diabetes. Other risk factors should also be controlled with a more ambitious strategy applied in the younger patients with shorter diabetes duration, but a more cautious approach in the elderly and frail patients with a number of vascular or non-vascular co-morbidities. In patients from East Asia, such as China, the stroke risk is relatively higher than the risk of coronary events. This must also be taken into consideration for individualized goal setting in relation to total risk, for example in patients from stroke-prone families. In conclusion, the current strategy is to have a more individualized approach to risk factor control in patients with type 2 diabetes, also relevant for blood pressure control.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Adler, A.I., Stratton, I.M., Neil, H.A., Yudkin, J.S., Matthews, D.R., Cull, C.A., Wright, A.D., Turner, R.C., Holman, R.R., 2000. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ, 321(7258):412–419. [doi:10.1136/bmj.321.7258.412]

    Article  PubMed  CAS  Google Scholar 

  • ADVANCE Collaborative Group, 2007. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet, 370(9590):829–840. [doi:10.1016/S0140-6736(07)61303-8]

    Article  Google Scholar 

  • American Diabetes Association, 2011. Standards of medical care in diabetes—2011. Diabetes Care, 34(Suppl. 1): S11–S61. [doi:10.2337/dc11-S011]

    Article  Google Scholar 

  • Anderson, R.J., Bahn, G.D., Moritz, T.E., Kaufman, D., Abraira, C., Duckworth, W., for the VADT Study Group, 2011. Blood pressure and cardiovascular disease risk in the Veterans Affairs Diabetes Trial. Diabetes Care, 34(1): 34–38. [doi:10.2337/dc10-1420]

    Article  PubMed  Google Scholar 

  • Bangalore, S., Messerli, F.H., Wun, C.C., Zuckerman, A.L., DeMicco, D., Kostis, J.B., LaRosa, J.C., for the Treating to New Targets Steering Committee and Investigators, 2009. J-curve revisited: an analysis of the Treating to New Targets (TNT) trial. J. Am. Coll. Cardiol., 53:A217.

    Google Scholar 

  • Bangalore, S., Messerli, F.H., Wun, C.C., Zuckerman, A.L., DeMicco, D., Kostis, J.B., LaRosa, J.C., for the Treating to New Targets Steering Committee and Investigators, 2010. J-curve revisited: an analysis of blood pressure and cardiovascular events in the Treating to New Targets (TNT) trial. Eur. Heart J., 31(23):2897–2908. [doi:10.1093/eurheartj/ehq328]

    Article  PubMed  CAS  Google Scholar 

  • Bangalore, S., Kumar, S., Lobach, I., Messerli, F.H., 2011. Blood pressure targets in subjects with type 2 diabetes mellitus/impaired fasting glucose: observations from traditional and bayesian random-effects meta-analyses of randomized trials. Circulation, 123(24):2799–2810. [doi:10.1161/CIRCULATIONAHA.110.016337]

    Article  PubMed  CAS  Google Scholar 

  • Buse, J.B., Ginsberg, H.N., Bakris, G.L., Clark, N.G., Costa, F., Eckel, R., Fonseca, V., Gerstein, H.C., Grundy, S., Nesto, R.W., et al., 2007. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation, 115(1):114–126. [doi:10.1161/CIRCULATIONAHA.106.179294]

    Article  PubMed  Google Scholar 

  • Cederholm, J., Nilsson, P.M., Eliasson, B., Eeg-Olofsson, K., Zethelius, B., Gudbjörnsdottir, S., 2009a. Connections between risk factors and complications in diabetes. A report after 13 years with the National Diabetes Registry (NDR). Lakartidningen, 106:2684–2689 (in Swedish).

    PubMed  Google Scholar 

  • Cederholm, J., Zethelius, B., Nilsson, P.M., Eeg-Olofsson, K., Eliasson, B., Gudbjörnsdottir, S., 2009b. Effect of tight control of HbA1c and blood pressure on cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR). Diab. Res. Clin. Pract., 86(1):74–81. [doi:10.1016/j.diabres.2009.07.003]

    Article  CAS  Google Scholar 

  • Cederholm, J., Gudbjörnsdottir, S., Eliasson, B., Zethelius, B., Eeg-Olofsson, K., Nilsson, P.M., 2010. Systolic blood pressure and risk of cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register. J. Hypertens., 28(10): 2026–2035.

    PubMed  CAS  Google Scholar 

  • Cooper-Dehoff, R.M., Gong, Y., Handberg, E.M., Bavry, A.A., Denardo, S.J., Bakris, G.L., Pepine, C.J., 2010. Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. JAMA, 304(1):61–68. [doi:10.1001/jama.2010.884]

    Article  PubMed  CAS  Google Scholar 

  • Edelman, D., Fredrickson, S.K., Melnyk, S.D., Coffman, C.J., Jeffreys, A.S., Datta, S., Jackson, G.L., Harris, A.C., Hamilton, N.S., Stewart, H., et al., 2010. Medical clinics versus usual care for patients with both diabetes and hypertension: a randomized trial. Ann. Intern. Med., 152(11):689–696.

    PubMed  Google Scholar 

  • Eeg-Olofsson, K., Cederholm, J., Nilsson, P.M., Gudbjörnsdottir, S., Eliasson, B., for the Steering Committee of the Swedish National Diabetes Register, 2007. Glycemic and risk factor control in type 1 diabetes. results from 13 612 patients in a national diabetes register. Diabetes Care, 30(3):496–502. [doi:10.2337/dc06-1406]

    Article  PubMed  Google Scholar 

  • Eeg-Olofsson, K., Cederholm, J., Nilsson, P.M., Zethelius, B., Svensson, A.M., Gudbjörnsdottir, S., Eliasson, B., 2010a. Glycemic control and cardiovascular disease in 7 454 patients with type 1 diabetes. An observational study from the Swedish National Diabetes Register. Diabetes Care, 33(7):1640–1646. [doi:10.2337/dc10-0398]

    CAS  Google Scholar 

  • Eeg-Olofsson, K., Cederholm, J., Nilsson, P.M., Zethelius, B., Svensson, A.M., Gudbjörnsdottir, S., Eliasson, B., 2010b. New aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR). J. Intern. Med., 268(5):471–482. [doi:10.1111/j.1365-2796.2010.02265.x]

    Article  PubMed  CAS  Google Scholar 

  • Franklin, S.S., 2010. Isolated systolic hypertension and the J-curve of cardiovascular disease risk. Artery Res., 4(1):1–6. [doi:10.1016/j.artres.2010.01.001]

    Article  Google Scholar 

  • Gæde, P., Vedel, P., Larsen, N., Jensen, G.V., Parving, H.H., Perdersen, O., 2003. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N. Engl. J. Med., 348(5):383–393. [doi:10.1056/NEJMoa021778]

    Article  PubMed  Google Scholar 

  • Gerstein, H.C., Miller, M.E., Byington, R.P., Goff, D.C.Jr., Bigger, J.T., Buse, J.B., Cushman, W.C., Genuth, S., Probstfield, J.L., Simons-Morton, D.G., et al., 2008. Effects of intensive glucose lowering in type 2 diabetes. N. Engl. J. Med., 358(24):2545–2559. [doi:10.1056/NEJMoa0802743]

    Article  PubMed  CAS  Google Scholar 

  • Grossman, E., Messerli, F.H., 2011. Management of blood pressure in patients with diabetes. Am. J. Hypertens. [Epub ahead of print]. [doi:10.1038/ajh.2011.77]

  • Hanefeld, M., Fischer, S., Julius, U., Schulze, J., Schwanebeck, U., Schmechel, H., Ziegelasch, H.J., Lindner, J., the DIS Group, 1996. Risk factors for myocardial infarction and death in newly detected NIDDM: the diabetes intervention study, 11-year follow-up. Diabetologia, 39(12):1577–1583. [doi:10.1007/s001250050617]

    Article  PubMed  CAS  Google Scholar 

  • Hansson, L., Zanchetti, A., Carruthers, S.G., Dahlof, B., Elmfeldt, D., Julius, S., Ménard, J., Rahn, K.H., Wedel, H., Westerling, S., 1998. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the hypertension optimal treatment (HOT) randomised trial. Lancet, 351(9118): 1755–1762. [doi:10.1016/S0140-6736(98)04311-6]

    Article  PubMed  CAS  Google Scholar 

  • Heart Outcomes Prevention Evaluation (HOPE) Study Investigators, 2000. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet, 355(9200):253–259. [doi:10.1016/S0140-6736(99)12323-7]

    Article  Google Scholar 

  • Jamerson, K., Weber, M.A., Bakris, G.L., Dahlof, B., Pitt, B., Shi, V., Hester, A., Gupte, J., Gatlin, M., Velazquez, E.J., ACCOMPLISH Trial Investigators, 2008. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N. Engl. J. Med., 359(23): 2417–2428. [doi:10.1056/NEJMoa0806182]

    Article  PubMed  CAS  Google Scholar 

  • Kelly, T.N., Bazzano, L.A., Fonseca, V.A., Thethi, T.K., Reynolds, K., He, J., 2009. Glucose control and cardiovascular disease in type 2 diabetes. Ann. Intern. Med., 151(6):394–403.

    PubMed  Google Scholar 

  • Mancia, G., de Backer, G., Dominiczak, A., Cifkova, R., Fagard, R., Germano, G., Grassi, G., Heagerty, A., Kjeldsen, S.E., Laurent, S., et al., 2007. 2007 guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens., 25(6):1105–1187. [doi:10.1097/HJH.0b013e3281fc975a]

    Article  PubMed  CAS  Google Scholar 

  • Mancia, G., Laurent, S., Agabiti-Rosei, E., Ambrosioni, E., Burnier, M., Caulfield, M.J., Cifkova, R., Clément, D., Coca, A., Dominiczak, A., et al., 2009. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J. Hypertens., 27(11):2121–2158. [doi:10.1097/HJH.0b013e328333146d]

    Article  PubMed  CAS  Google Scholar 

  • Mannucci, E., Monami, M., Lamanna, C., Gori, F., Marchionni, N., 2009. Prevention of cardiovascular disease through glycemic control in type 2 diabetes: a meta-analysis of randomized clinical trials. Nutr. Metab. Cardiovasc. Dis., 19(9):604–612. [doi:10.1016/j.numecd.2009.03.021]

    Article  PubMed  CAS  Google Scholar 

  • Messerli, F.H., Mancia, G., Conti, C.R., Hewkin, A.C., Kupfer, S., Champion, A., Kolloch, R., Benetos, A., Pepine, C.J., 2006. Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann. Intern. Med., 144(12): 884–893.

    PubMed  Google Scholar 

  • Nathan, D.M., Cleary, P.A., Backlund, J.Y., Genuth, S.M., Lachin, J.M., Orchard, T.J., Raskin, P., Zinman, B., 2005. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N. Engl. J. Med., 353(25): 2643–2653. [doi:10.1056/NEJMoa052187]

    Article  PubMed  Google Scholar 

  • Nilsson, P.M., 2010. ACCORD and risk-factor control in type 2 diabetes. N. Engl. J. Med., 362(17):1628–1630. [doi:10.1056/NEJMe1002498]

    Article  PubMed  CAS  Google Scholar 

  • Nilsson, P.M., Cederholm, J., 2011. Diabetes, hypertension, and outcome studies: overview 2010. Diabetes Care, 34(Suppl. 2):S109–S113. [doi:10.2337/dc11-s204]

    Article  PubMed  Google Scholar 

  • Nilsson, P.M., Cederholm, J., Eliasson, B., Eeg-Olofsson, K., Zethelius, B., Gudbjörnsdottir, S., 2011a. Different statistical methods to present the effect of attained blood pressure on CVD risk in diabetes by use of Cox regression. J. Hypertens., 29(e-Suppl. A):e238.

    Google Scholar 

  • Nilsson, P.M., Cederholm, J., Zethelius, B., Eliasson, B., Eeg-Olofsson, K., Gudbjörnsdottir, S., 2011b. Trends in blood pressure control in patients with type 2 diabetes—data from the Swedish National Diabetes Register (NDR). Blood Pressure [Epub ahead of print]. [doi:10.3109/08037051.2011.587288]

  • O’Donnell, M.J., Xavier, D., Liu, L., Zhang, H., Chin, S.L., Rao-Melacini, P., Rangarajan, S., Islam, S., Pais, P., McQueen, M.K., et al., 2010. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet, 376(9735):112–123. [doi:10.1016/S0140-6736(10)60834-3]

    Article  PubMed  Google Scholar 

  • Patel, A., MacMahon, S., Chalmers, J., Neal, B., Woodward, M., Billot, L., Harrap, S., Poulter, N., Marre, M., Cooper, M., et al., 2007. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet, 370(9590):829–840. [doi:10.1016/S0140-6736(07)61303-8]

    Article  PubMed  CAS  Google Scholar 

  • Pepine, C.J., Handberg, E.M., Cooper-DeHoff, R.M., Marks, R.G., Kowey, P., Messerli, F.H., Mancia, G., Cangiano, J.L., Garcia-Barreto, D., Keltai, M., et al., 2003. A calcium antagonist vs. a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The international verapamil-trandolapril study (INVEST): a randomized controlled trial. JAMA, 290(21):2805–2816. [doi:10.1001/jama.290.21.2805]

    CAS  Google Scholar 

  • Ray, K.K., Seshasai, S.R., Wijesuriya, S., Sivakumaran, R., Nethercott, S., Preiss, D., Erqou, S., Sattar, N., 2009. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet, 373(9677):1765–1772. [doi:10.1016/S0140-6736(09)60697-8]

    Article  PubMed  CAS  Google Scholar 

  • Reboldi, G., Gentile, G., Angeli, F., Ambrosio, G., Mancia, G., Verdecchia, P., 2011. Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73 913 patients. J. Hypertens., 29(7): 1253–1269. [doi:10.1097/HJH.0b013e3283469976]

    Article  PubMed  CAS  Google Scholar 

  • Redon, J., Sleight, P., Mancia, G., Gao, O., Verdecchia, P., Fagard, R., Schumacher, H., Weber, M., Boehm, M., Williams, B., et al., 2009. Safety and efficacy of aggressive blood pressure lowering among patients with diabetes: subgroup analyses from the ONTARGET trial. J. Hypertens., 27(Suppl. 4):S16.

    Google Scholar 

  • Redon, J., Mancia, G., Sleight, P., Schumacher, H., Gao, P., Pogue, J., Fagard, R., Verdecchia, P., Weber, M., Böhm, M., et al., 2011. Safety and efficacy of low blood pressure among patients with diabetes: sub-group analyses from the ONTARGET trial. J. Hypertens., 29(e-Suppl. A): e113.

    Google Scholar 

  • Rydén, L., Standl, E., Bartnik, M., van den Berghe, G., Betteridge, J., de Boer, M.J., Cosentino, F., Jönsson, B., Laakso, M., Malmberg, K., et al., 2007. The task force on diabetes and cardiovascular diseases of the European Society of Cardiology (ESC) and of the European Association for the study of diabetes (EASD). Guidelines on diabetes, prediabetes, and cardiovascular diseases: executive summary. Eur. Heart J., 28(1):88–136.

    Article  PubMed  Google Scholar 

  • Saydah, S.H., Fradkin, J., Cowie, C.C., 2004. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA, 291(3):335–342. [doi:10.1001/jama.291.3.335]

    Article  PubMed  CAS  Google Scholar 

  • Sleight, P., Redon, J., Verdecchia, P., Mancia, G., Gao, P., Fagard, R., Schumacher, H., Weber, M., Böhm, M., Williams, B., et al., 2009. Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study. J. Hypertens., 27(7): 1360–1369. [doi:10.1097/HJH.0b013e32832d7370]

    Article  PubMed  CAS  Google Scholar 

  • Stamler, J., Vaccaro, O., Neaton, J.D., Wentworth, D., 1993. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care, 16(2):434–444. [doi:10.2337/diacare.16.2.434]

    Article  PubMed  CAS  Google Scholar 

  • Stratton, I.M., Cull, C.A., Adler, A.I., Matthews, D.R., Neil, H.A.W., Holman, R.R., 2006. Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75). Diabetologia, 49(8):1761–1769. [doi:10.1007/s00125-006-0297-1]

    Article  PubMed  CAS  Google Scholar 

  • Telmisartan Randomised Assessment Study in ACE intolerant Subjects with Cardiovascular Disease (TRANSCEND) Investigators, 2008. Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial. Lancet, 372(9644): 1174–1183. [doi:10.1016/S0140-6736(08)61242-8]

    Article  Google Scholar 

  • The ACCORD Study Group, 2010. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N. Engl. J. Med., 362(17):1575–1582. [doi:10.1056/NEJMoa1001286]

    Article  Google Scholar 

  • Tseng, D.S., Kwong, J., Rezvani, F., Coates, A.O., 2010. Angiotensin-converting enzyme-related cough among Chinese-Americans. Am. J. Med., 123(2):183.e11–e15. [doi:10.1016/j.amjmed.2009.06.032]

    Article  Google Scholar 

  • Turnbull, F., Neal, B., Algert, C., Chalmers, J., Chapman, N., Cutler, J., Woodward, M., MacMahon, S., 2005. Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials. Arch. Intern. Med., 165(12):1410–1419.

    Article  PubMed  Google Scholar 

  • Turnbull, F.M., Abraira, C., Anderson, R.J., Byington, R.P., Chalmers, J.P., Duckworth, W.C., Evans, G.W., Gerstein, H.C., Holman, R.R., Moritz, T.E., et al., 2009. Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia, 52(11):2288–2298. [doi:10.1007/s00125-009-1470-0]

    Article  PubMed  CAS  Google Scholar 

  • Turner, R.C., Millns, H., Neil, H.A., Stratton, I.M., Manley, S.E., Matthews, D.R., Holman, R.R., 1998. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23). BMJ, 316:823–828.

    PubMed  CAS  Google Scholar 

  • UK Prospective Diabetes Study Group, 1998. Tight blood pressure control and risk of macrovascular complications in type-2 diabetes: UKPDS 38. BMJ, 317:703–713.

    Google Scholar 

  • Yach, D., Hawkes, C., Gould, C.L., Hofman, K.J., 2004. The global burden of chronic diseases: overcoming impediments to prevention and control. JAMA, 291(21): 2616–2622. [doi:10.1001/jama.291.21.2616]

    Article  PubMed  CAS  Google Scholar 

  • Yusuf, S., Diener, H.C., Sacco, R.L., Cotton, D., Ounpuu, S., Lawton, W.A., Palesch, Y., Martin, R.H., Albers, G.W., Bath, P., et al., 2008. PRoFESS Study Group. Telmisartan to prevent recurrent stroke and cardiovascular events. N. Engl. J. Med., 359(12):1225–1237. [doi:10.1056/NEJMoa0804593]

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Sciences, Lund University, University Hospital, S-205 02, Malmö, Sweden

    Peter M. Nilsson

Authors
  1. Peter M. Nilsson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Peter M. Nilsson.

Additional information

Project (No. VR2009-1032) supported by a Strategic Research Grant for Excellence in Epidemiological Research from the Research Council, Sweden, to the Lund University for which the author is the coordinator (www.med.lu.se/epihealth)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nilsson, P.M. Target blood pressure in diabetes patients with hypertension —What is the accumulated evidence in 2011?. J. Zhejiang Univ. Sci. B 12, 611–623 (2011). https://doi.org/10.1631/jzus.B1101001

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1631/jzus.B1101001

Key words

CLC number

Search

Navigation